Pauls Matthew
SEC Form 4 insider trading activity
Pauls Matthew has filed 8 SEC Form 4 filings (13 transaction rows) across 3 companies, including PTHS, SLNO, SVRA, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Oct 6, 2026.
On the most recent filing, Pauls Matthew is listed as Director at Pelthos Therapeutics Inc. Inside the rolling window, Pauls Matthew reported no open-market purchases and 3 open-market sales totaling $54K in PTHS. The largest disclosed transaction in the window is a sale of 786 PTHS shares on Jul 2, 2026, worth $21K.
Companies traded
Other insiders at PTHS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$54K
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Pauls Matthew made?
Pauls Matthew has filed 8 SEC Form 4 filings (13 transaction rows) across 3 companies, including PTHS, SLNO, SVRA since 2025.
Which companies does Pauls Matthew trade?
Pauls Matthew has filed SEC Form 4 disclosures for 3 companies, including PTHS, SLNO, SVRA.
When was Pauls Matthew's most recent SEC Form 4 filing?
Pauls Matthew's most recent SEC Form 4 filing on Tracefour is dated Oct 6, 2026.
What is Pauls Matthew's total buy and sell value in the current window?
Inside the rolling retention window, Pauls Matthew bought $0 and sold $54K based on SEC Form 4 filings.
What was Pauls Matthew's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 786 PTHS shares on 2026-07-02, worth $21K, per SEC Form 4 filings.